Taro Pharmaceutical Industries Ltd

JPMORGAN CHASE & CO

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/10/2024

Shares

12,477

Value ($000)

528

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/10/2024	528	0.0%	12,477	3/31/2024
2023 Q4	2/12/2024	265	0.0%	6,350	12/31/2023
2023 Q3	11/14/2023	242	0.0%	6,413	9/30/2023
2023 Q2	8/11/2023	255	0.0%	6,718	6/30/2023
2023 Q1	5/18/2023	30	0.0%	1,222	3/31/2023
2022 Q4	2/13/2023	26	0.0%	917	12/31/2022
2022 Q3	11/14/2022	31	0.0%	1,057	9/30/2022
2022 Q2	8/11/2022	121	0.0%	3,340	6/30/2022
2022 Q1	5/11/2022	35	0.0%	817	3/31/2022
2021 Q4	2/11/2022	200	0.0%	3,995	12/31/2021
2021 Q3	11/12/2021	815	0.0%	12,801	9/30/2021
2021 Q2	8/12/2021	2,196	0.0%	30,528	6/30/2021
2021 Q1	5/12/2021	2,491	0.0%	33,776	3/31/2021
2020 Q4	2/19/2021	782	0.0%	10,655	12/31/2020
2020 Q3	11/12/2020	653	0.0%	11,976	9/30/2020
2020 Q2	8/11/2020	250	0.0%	3,764	6/30/2020
2020 Q1	5/12/2020	2,099	0.0%	34,298	3/31/2020
2019 Q4	2/11/2020	4,272	0.0%	48,586	12/31/2019